358 related articles for article (PubMed ID: 11514380)
1. Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability.
Cipollone F; Prontera C; Pini B; Marini M; Fazia M; De Cesare D; Iezzi A; Ucchino S; Boccoli G; Saba V; Chiarelli F; Cuccurullo F; Mezzetti A
Circulation; 2001 Aug; 104(8):921-7. PubMed ID: 11514380
[TBL] [Abstract][Full Text] [Related]
2. Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans.
Cipollone F; Fazia M; Iezzi A; Zucchelli M; Pini B; De Cesare D; Ucchino S; Spigonardo F; Bajocchi G; Bei R; Muraro R; Artese L; Piattelli A; Chiarelli F; Cuccurullo F; Mezzetti A
Circulation; 2003 Mar; 107(11):1479-85. PubMed ID: 12654603
[TBL] [Abstract][Full Text] [Related]
3. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control.
Cipollone F; Iezzi A; Fazia M; Zucchelli M; Pini B; Cuccurullo C; De Cesare D; De Blasis G; Muraro R; Bei R; Chiarelli F; Schmidt AM; Cuccurullo F; Mezzetti A
Circulation; 2003 Sep; 108(9):1070-7. PubMed ID: 12912808
[TBL] [Abstract][Full Text] [Related]
4. Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity.
Cipollone F; Fazia M; Iezzi A; Pini B; Cuccurullo C; Zucchelli M; de Cesare D; Ucchino S; Spigonardo F; De Luca M; Muraro R; Bei R; Bucci M; Cuccurullo F; Mezzetti A
Circulation; 2004 Mar; 109(12):1482-8. PubMed ID: 15037537
[TBL] [Abstract][Full Text] [Related]
5. Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans.
Cipollone F; Fazia M; Iezzi A; Ciabattoni G; Pini B; Cuccurullo C; Ucchino S; Spigonardo F; De Luca M; Prontera C; Chiarelli F; Cuccurullo F; Mezzetti A
Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1259-65. PubMed ID: 15155382
[TBL] [Abstract][Full Text] [Related]
6. Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human.
Cipollone F; Fazia ML; Iezzi A; Cuccurullo C; De Cesare D; Ucchino S; Spigonardo F; Marchetti A; Buttitta F; Paloscia L; Mascellanti M; Cuccurullo F; Mezzetti A
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1925-31. PubMed ID: 16020747
[TBL] [Abstract][Full Text] [Related]
7. Microsomal prostaglandin E synthase-1, which is not coupled to a particular cyclooxygenase isoenzyme, is essential for prostaglandin E(2) biosynthesis in vascular smooth muscle cells.
Camacho M; Gerbolés E; Escudero JR; Antón R; García-Moll X; Vila L
J Thromb Haemost; 2007 Jul; 5(7):1411-9. PubMed ID: 17403097
[TBL] [Abstract][Full Text] [Related]
8. Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4.
Thorén S; Jakobsson PJ
Eur J Biochem; 2000 Nov; 267(21):6428-34. PubMed ID: 11029586
[TBL] [Abstract][Full Text] [Related]
9. Association between 5-lipoxygenase expression and plaque instability in humans.
Cipollone F; Mezzetti A; Fazia ML; Cuccurullo C; Iezzi A; Ucchino S; Spigonardo F; Bucci M; Cuccurullo F; Prescott SM; Stafforini DM
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1665-70. PubMed ID: 15933245
[TBL] [Abstract][Full Text] [Related]
10. A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke.
Cipollone F; Toniato E; Martinotti S; Fazia M; Iezzi A; Cuccurullo C; Pini B; Ursi S; Vitullo G; Averna M; Arca M; Montali A; Campagna F; Ucchino S; Spigonardo F; Taddei S; Virdis A; Ciabattoni G; Notarbartolo A; Cuccurullo F; Mezzetti A;
JAMA; 2004 May; 291(18):2221-8. PubMed ID: 15138244
[TBL] [Abstract][Full Text] [Related]
11. [New insights on the molecular mechanisms of type-1 angiotensin II receptor blockers and their contribution to atherosclerotic plaque stabilization].
Mezzetti A; Fazia M; Cipollone F
Recenti Prog Med; 2004 Dec; 95(12):586-90. PubMed ID: 15666492
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of COX-2, Prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: regulation by nuclear factor-kappaB.
Gómez-Hernández A; Martín-Ventura JL; Sánchez-Galán E; Vidal C; Ortego M; Blanco-Colio LM; Ortega L; Tuñón J; Egido J
Atherosclerosis; 2006 Jul; 187(1):139-49. PubMed ID: 16212965
[TBL] [Abstract][Full Text] [Related]
13. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2.
Caughey GE; Cleland LG; Penglis PS; Gamble JR; James MJ
J Immunol; 2001 Sep; 167(5):2831-8. PubMed ID: 11509629
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques.
Cipollone F; Fazia M; Mincione G; Iezzi A; Pini B; Cuccurullo C; Ucchino S; Spigonardo F; Di Nisio M; Cuccurullo F; Mezzetti A; Porreca E
Stroke; 2004 Oct; 35(10):2253-7. PubMed ID: 15297631
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological modulation of plaque instability.
Mezzetti A
Lupus; 2005; 14(9):769-72. PubMed ID: 16218485
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E synthase: a novel drug target for inflammation and cancer.
Murakami M; Kudo I
Curr Pharm Des; 2006; 12(8):943-54. PubMed ID: 16533161
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions.
Hong BK; Kwon HM; Lee BK; Kim D; Kim IJ; Kang SM; Jang Y; Cho SH; Kim HK; Jang BC; Cho SY; Kim HS; Kim MS; Kwon HC; Lee N
Yonsei Med J; 2000 Feb; 41(1):82-8. PubMed ID: 10731924
[TBL] [Abstract][Full Text] [Related]
18. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis.
Tanioka T; Nakatani Y; Semmyo N; Murakami M; Kudo I
J Biol Chem; 2000 Oct; 275(42):32775-82. PubMed ID: 10922363
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts.
Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S
Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087
[TBL] [Abstract][Full Text] [Related]
20. Monocyte cyclooxygenase-2 activity: a new therapeutic target for atherosclerosis?
Páramo JA; Rodríguez JA; Beloqui O; Orbe J
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Aug; 5(4):303-11. PubMed ID: 16101563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
